NY-0123

Names

[ CAS No. ]:
1801911-70-5

[ Name ]:
NY-0123

Biological Activity

[Description]:

NY-0123 is a novel potent Exchange proteins directly activated by cAMP (EPAC) antagonist with IC50 of 0.9 and 2.4 uM for EPAC1 and EPAC2, respectively; NY0123 is more potent than ESI-09, and is a valuable pharmacological probes to facilitate our efforts in elucidating the biological functions of EPAC and developing potential novel therapeutics against human diseases.

[References]

References 1. Ye N, et al. J Med Chem. 2015 Aug 13;58(15):6033-47. View Related Products by Target Other Targets

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₆H₁₃Cl₃N₄O₂

[ Molecular Weight ]:
399.656

Related Compounds

NY-0173
NY-BR-1 p904 A2
NY-ESO-1 (87-111)
PCI-0123
Debio-0123
yttrium nitride
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
4-(4-(Pyrrolidin-3-yl)phenyl)pyridine
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
tert-Butyl-DL-alanine
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide